LBF18107PG01: Difference between revisions
No edit summary |
No edit summary |
(No difference)
|
Revision as of 00:03, 20 December 2008
IDs and Links | |
---|---|
LipidBank | XPR1821 |
LipidMaps | LMFA03010089 |
CAS | |
KEGG | {{{KEGG}}} |
KNApSAcK | {{{KNApSAcK}}} |
mol | LBF18107PG01 |
2,3-dinor-6-ketoprostaglandin F_1α | |
---|---|
Structural Information | |
5- [ 3 (R) ,5 (S) -Dihydroxy-2 (R) - (3 (S) -hydroxy-1 (E) -octenyl) cyclopentan-1 (R) -yl ] -4-oxopentanoic acid | |
| |
Formula | C18H30O6 |
Exact Mass | 342.204238692 |
Average Mass | 342.42719999999997 |
SMILES | [C@@H]([C@@H](CC(=O)CCC(O)=O)1)(C=C[C@H](O)CCCCC)[C@H](O)C[C@@H]1O |
Physicochemical Information | |
METHANOL Pace-Asciak_CR et al. | |
Spectral Information | |
Mass Spectra | METHOXIME TRI-TMS ETHER METHYL ESTER ; m/e 601(M+), 586, 570, 530, 511, 496, 480, 440, 421, 390, 350, 300, 294, 263, 217, 205, 191, 73 Pace-Asciak_CR et al. |
UV Spectra | |
IR Spectra | |
NMR Spectra | |
Other Spectra | |
Chromatograms |
Reported Metabolites, References | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|